Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
暂无分享,去创建一个
Cynthia A. Toth | Emily Y. Chew | Paul S. Bernstein | Thomas R. Friberg | Philip J. Rosenfeld | Amitha Domalpally | Ronald P. Danis | Elvira Agrón | Wai T. Wong | Andrew N. Antoszyk | Michael J. Elman | Barbara A. Blodi | E. Agrón | S. Bressler | P. Rosenfeld | F. Ferris | J. Sangiovanni | E. Chew | G. Fish | M. Elman | P. Bernstein | R. Danis | W. Wong | M. Klein | T. Clemons | A. Ruby | D. Orth | T. Friberg | C. Toth | B. Blodi | A. Domalpally | A. Antoszyk | S. Chandra | Traci E. Clemons | Michael L. Klein | Frederick L. Ferris | John Paul SanGiovanni | Alan J. Ruby | David H. Orth | Susan B. Bressler | Suresh R. Chandra | Gary E. Fish | Baker Hubbard | Robert Sperdut | Baker Hubbard | Robert Sperdut
[1] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[2] E. Souied,et al. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. , 2013, Ophthalmology.
[3] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[4] Peter K. Kaiser,et al. ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006 .
[5] M. Hambidge. Underwood Memorial Lecture: human zinc homeostasis: good but not perfect. , 2003, The Journal of nutrition.
[6] M R Cullen,et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.
[7] J. Buring,et al. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. , 2008, Archives of ophthalmology.
[8] F. Ferris,et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. , 2007, Archives of ophthalmology.
[9] F. Ferris,et al. Dose-ranging study of lutein supplementation in persons aged 60 years or older. , 2006, Investigative ophthalmology & visual science.
[10] G. Steinbeck,et al. OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction , 2010, Circulation.
[11] K. Yeum,et al. Carotenoid bioavailability and bioconversion. , 2003, Annual review of nutrition.
[12] The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. , 2001, American journal of ophthalmology.
[13] F. Barrantes,et al. Docosahexaenoic Acid Is Required for the Survival of Rat Retinal Photoreceptors In Vitro , 1996, Journal of neurochemistry.
[14] U. Schmidt-Erfurth,et al. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[15] Chris A. Johnson,et al. A COMPUTERIZED METHOD OF VISUAL ACUITY TESTING: ADAPTATION OF THE EARLY TREATMENT OF DIABETIC RETINOPATHY STUDY TESTING PROTOCOL , 2003 .
[16] W. White,et al. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. , 1995, The American journal of clinical nutrition.
[17] J. Gerss,et al. Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. , 2011, Investigative ophthalmology & visual science.
[18] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[19] P. D. de Jong,et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. , 2008, The American journal of clinical nutrition.
[20] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[21] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[22] W. Willett,et al. The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.
[23] L. J. Wei,et al. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .
[24] E. Agrón,et al. {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. , 2009, The American journal of clinical nutrition.
[25] W. Willett,et al. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. , 2012, The American journal of clinical nutrition.
[26] Emily Y. Chew,et al. The Age-related Eye Disease Study 2 ( AREDS 2 ) Study Design and Baseline Characteristics ( AREDS 2 Report , 2012 .
[27] J. Palmgren,et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. , 1995, The American journal of clinical nutrition.
[28] Jonghyeon Kim,et al. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD. , 2008, Investigative ophthalmology & visual science.
[29] S. Connor,et al. Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene , 2010, European journal of nutrition.
[30] Usha Chakravarthy,et al. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. , 2013, Ophthalmology.
[31] Lawrence A. Yannuzzi,et al. Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .
[32] D. Mozaffarian,et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. , 2012, JAMA.
[33] R. Elston,et al. Oral zinc in macular degeneration. , 1988, Archives of ophthalmology.
[34] H. Dou,et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. , 2012, Ophthalmology.
[35] R Hiller,et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.
[36] S. Richer,et al. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. , 2011, Optometry.
[37] F. Delori,et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. , 2002, Investigative ophthalmology & visual science.
[38] Stuart Richer,et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). , 2004, Optometry.